A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II

BACKGROUND: Lertal®, an oral nutraceutical, contains extract of Perilla, quercetin, and Vitamin D3. The current polycentric, randomized, parallel-group, controlled study aimed in the Phase II to evaluate the efficacy and safety of Lertal® in preventing allergic rhinitis (AR) exacerbations in childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Marseglia, Gianluigi, Licari, Amelia, Leonardi, Salvatore, Papale, Maria, Zicari, Anna Maria, Schiavi, Laura, Ciprandi, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637471/
https://www.ncbi.nlm.nih.gov/pubmed/31319883
http://dx.doi.org/10.1186/s13052-019-0678-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637471/
https://www.ncbi.nlm.nih.gov/pubmed/31319883
http://dx.doi.org/10.1186/s13052-019-0678-y

Ejemplares similares